Commentary · 31 Jan 2025
Short communicationPublished 21 Jul 2020
Drug Discovery Meet 2020- SIRT6 small molecule modulator as a potential anti-inflammatory treatment for targeting TNF-ɑ related disorders
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
SIRT6 is a NAD+ dependent deacylase enzyme with a key role in ageing, metabolism and inflammation. Chronic inflammation conditions are often characterized with uncontrolled Tumor Necrosis Factor Alpha (TNF-ɑ), cytokine production. Dysregulation of TNF-ɑ has been implicated in a variety of human diseases including inflammatory bowel disease, Alzheimer's disease, Amyotrophic lateral sclerosis and more. SIRT6 has a dual role in TNF-ɑ inflammatory pathways. SIRT6 can control TNF-ɑ secretion levels by a removal of a myristoyl group from TNF-ɑ K19. Upon deacylation, TNF-ɑ is localized to the cell membrane. If stayed acylated, it is more tended to be degraded by the cell lysosome. After secreted, TNF-ɑ enhancing the inflammatory response in target cells by activating nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB). On the other hand, SIRT6 regulates transcription factor NF-kB by deacetylating Histone 3 K9. Therefore, SIRT6 modulators could become future anti-inflammatory drugs for treating TNF-ɑ related disorders. In order to inhibit TNF-ɑ secretion, we aimed to modulate specifically SIRT6’s deacylation activity. We characterized SIRT6 activity and physical interaction with small compounds using a pipeline of in-vitro and in-silico assay systems. As a result, we were able to identify a novel small compound with the ability to modulate TNF-ɑ secretion. Therefore, we suggest this compound as a starting candidate in order to develop new anti-inflammatory drugs.
Subjects
ChemistryPharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Chemical Biology & Pharmaceutical Chemistry.
Brief report · 31 Jan 2025
Chemical Biology Approaches to Modulate Protein–protein Interactions in Cancer Therapy
Opinion · 31 Jan 2025
Advances in Nanocarrier-based Drug Delivery: Bridging Chemistry and Pharmacology
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Chemical Biology & Pharmaceutical Chemistry
- SubjectChemistry
- SubjectPharmaceutical Sciences
